Parmalat S.p.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:Parmalat S.p.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3819
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥23,100見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥46,200見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥69,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Parmalat S.p.A. – Strategy, SWOT and Corporate Finance Report
Summary

Parmalat S.p.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Parmalat S.P.A (Parmalat) is a manufacturer and distributor of food products and beverages. The company’s product portfolio comprises of ultra-high temperature milk, flavoured milk, condensed milk, milk powder, fruit juices, soy drinks, tea and yogurt. It also offers probiotics, desserts, cheese, ice cream, ingredients and butter. The company markets products under Parmalat, Santal, Zymil, Vaalia, Fibresse, and Omega3 brand names. It has business presence in Italy, Russia, Portugal, and Australia. Parmalat develops products through its six R&D centers located in Australia, Canada, Italy, South Africa, the US, Brazil, Colombia and Venezuela. Parmalat is headquartered in Collecchio, Parma, Italy.

Scope

- Detailed information on Parmalat S.p.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Parmalat S.p.A. in the form of a SWOT analysis
- An in-depth view of the business model of Parmalat S.p.A. including a breakdown and examination of key business segments
- Intelligence on Parmalat S.p.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Parmalat S.p.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Parmalat S.p.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Parmalat S.p.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Parmalat S.p.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Parmalat S.p.A.: Company Overview 8
Parmalat S.p.A.: Overview and Key Facts 8
Parmalat S.p.A.: Overview 8
Parmalat S.p.A.: Key Facts 8
Parmalat S.p.A.: Key Employees 10
Parmalat S.p.A.: Key Employee Biographies 12
Parmalat S.p.A.: Major Products and Services 14
Parmalat S.p.A.: Company History 16
Parmalat S.p.A.: Management Statement 20
Parmalat S.p.A.: Locations and Subsidiaries 23
Parmalat S.p.A.: Key Competitors 25
Parmalat S.p.A.: Company Analysis 26
Parmalat S.p.A.: Business Description 26
Parmalat S.p.A.: SWOT Analysis 27
Parmalat S.p.A.: SWOT Overview 27
Parmalat S.p.A.: Strengths 27
Parmalat S.p.A.: Weaknesses 28
Parmalat S.p.A.: Opportunities 28
Parmalat S.p.A.: Threats 29
Parmalat S.p.A.: Corporate Financial Deals Activity 30
Parmalat S.p.A.: Financial Deals Overview 30
Parmalat S.p.A.: Targets and Partners 31
Parmalat S.p.A.: Top Deals 2014 – 2018YTD* 32
Parmalat S.p.A.: Advisors 33
Parmalat S.p.A.: Top Financial Advisors 33
Parmalat S.p.A.: Mergers and Acquisitions 34
Parmalat S.p.A.: Private Equity and Ownership 35
Parmalat S.p.A.: Recent Developments 36
Parmalat S.p.A.: News and Events Summary 36
Parmalat S.p.A.: Business Reorganization 37
Parmalat S.p.A.: Corporate Governance 37
Parmalat S.p.A.: Financial Deals 38
Parmalat S.p.A.: Financial Performance 38
Parmalat S.p.A.: Research & Development 38
Appendix 40
Contact Us 40
Methodology 40
About MarketLine 41

List of Tables
Table 1: Parmalat S.p.A.: Key Facts
Table 2: Parmalat S.p.A.: Key Employees
Table 3: Parmalat S.p.A.: Locations and Subsidiaries
Table 4: Parmalat S.p.A.: Key Competitors
Table 5: Parmalat S.p.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Parmalat S.p.A.: M&A Average Deal Size - Value (US$m)
Table 7: Parmalat S.p.A.: Targets and Partners
Table 8: Parmalat S.p.A.: Top Deals 2014 - 2018YTD*
Table 9: Parmalat S.p.A.: Financial Advisor Ranking by Value (US$m)
Table 10: Parmalat S.p.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Parmalat S.p.A.: M&A Activity by Geography (2014 - YTD*2018)
Table 12: Parmalat S.p.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 13: Parmalat S.p.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 14: Parmalat S.p.A.: News and Events Summary
Table 15: Parmalat S.p.A.: Business Reorganization
Table 16: Parmalat S.p.A.: Corporate Governance
Table 17: Parmalat S.p.A.: Financial Deals
Table 18: Parmalat S.p.A.: Financial Performance
Table 19: Parmalat S.p.A.: Research & Development

List of Figures
Figure 1: Parmalat S.p.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Parmalat S.p.A.: M&A Average Deal Size - Value (US$m)
Figure 3: Parmalat S.p.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Parmalat S.p.A.: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Parmalat S.p.A.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Parmalat S.p.A.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Parmalat S.p.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Carmot Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company that discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company provides product portfolio such as encompasses investigational candidates in preclinical trials: peptide-sm …
  • Sumitomo Corp (8053):石油・ガス:M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …
  • Stellar Biotechnologies Inc (SBOT)-医療機器分野:企業M&A・提携分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Titan Petrochemicals Group Ltd (1192):石油・ガス:M&Aディール及び事業提携情報
    Summary Titan Petrochemicals Group Limited (Titan) is an investment holding company that carries out midstream energy and shipbuilding operations. It provides oil storage, transit, and blending services. The company transports oil and petrochemical products; and supplies oil products. Titan also car …
  • Advance Syntex Ltd:企業の戦略的SWOT分析
    Advance Syntex Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Dechra Pharmaceuticals PLC:企業のM&A・事業提携・投資動向
    Dechra Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dechra Pharmaceuticals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • STRATA Skin Sciences Inc (SSKN):企業の財務・戦略的SWOT分析
    STRATA Skin Sciences Inc (SSKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Charles River Laboratories International, Inc.:企業のM&A・事業提携・投資動向
    Charles River Laboratories International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Charles River Laboratories International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descriptio …
  • Highmark Inc-製薬・医療分野:企業M&A・提携分析
    Summary Highmark Inc (Highmark), a subsidiary of Highmark Health, is a provider of healthcare insurance solutions. The company underwrites various indemnities and offers healthcare insurance products to individuals, families, groups, companies and federal employees. In addition, the company provides …
  • Cleveland BioLabs Inc (CBLI)-医療機器分野:企業M&A・提携分析
    Summary Cleveland BioLabs Inc (Cleveland) is a biopharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein which acts as an agonist of …
  • Cutera Inc (CUTR):企業の財務・戦略的SWOT分析
    Cutera Inc (CUTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • UCB Inc-製薬・医療分野:企業M&A・提携分析
    Summary UCB Inc (UCB), a subsidiary of UCB SA is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, metad …
  • Leadiant Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Leadiant Biosciences Inc (Leadiant Biosciences), formerly Sigma-Tau Pharmaceuticals Inc, a subsidiary of Leadiant Biosciences SpA, is a pharmaceutical company that discovers and develops novel medicines. The company provides products such as abelcet, adagen, carnitor, cystaran, depocyt, matu …
  • Kentucky Power Co:企業の戦略的SWOT分析
    Kentucky Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • ALK-Abello AS (ALK B):企業の財務・戦略的SWOT分析
    ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Accu-Break Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Accu-Break Pharmaceuticals Inc (Accu-Break) is a developer and provider of pharmaceutical tablet technologies for accurate and customized dosing. The company provides services such as patented technologies, product differentiation, life cycle management, APIs solutions, product enhancement, …
  • Memorial Health System:企業の戦略的SWOT分析
    Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Clarion Co Ltd (6796):企業の財務・戦略的SWOT分析
    Clarion Co Ltd (6796) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY):企業の財務・戦略的SWOT分析
    Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Hey-Song Corporation:企業の戦略・SWOT・財務情報
    Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report Summary Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆